Archives of Disease in Childhood Fetal & Neonatal · 2020 · 17 citations · 5 references
MedicineChild HealthPediatricsNeonatal HealthNeonatologyPulmonologyInfant Respiratory CareNeonatal Intensive CareNeonatal Respiratory DisordersNeonatal SafetyNeonatal VentilationPediatric Respiratory CareExogenous Surfactant AdministrationFractional Inspired OxygenLung-protective Ventilation In NeonatesOutcome MeasuresPilot Study DesignPulmonary Surfactant AdministrationPulmonary Surfactant TherapySuccess Rate Analysis
Background Less-invasive surfactant administration (LISA) is increasingly used. We investigated the feasibility of a new LISA-device (Neofact®) in neonates. Design Prospective observational pilot study with open-label LISA in two tertiary neonatal intensive care units. Patients 20 infants with a gestational age of ≥26+0/7 weeks and an indication for LISA (Respiratory Severity Score (RSS)≥5 or fraction of inspired oxygen (FiO 2 ) ≥0.30). Infants with respiratory tract malformations or unavailability of an instructed neonatologist were excluded. Main outcome measures Success of LISA, defined as laryngoscopy-confirmed intratracheal catheter position or a decrease in FiO 2 by ≥0.05 or to 0.21, accompanied by an RSS decrease of ≥2; number of attempts needed for tracheal catheterisation. Results 20/57 screened infants were enrolled. Successful application occurred in 19/20 (95%). One application failed after three attempts. No device-related adverse events occurred. The median number of attempts was 2, success rate per attempt 19/31 (61%). Conclusion LISA via Neofact® appears feasible.
5
Implementation of Bubble CPAP in a Rural Ugandan Neonatal ICU
Ryan M. McAdams, Anna B. Hedstrom, Robert M DiBlasi et al. · Respiratory Care · 2014 · 79 citations · Full text
QuickSF: A New Technique in Surfactant Administration
Christian A. Maiwald, Patrick Neuberger, Matthias Vochem et al. · Neonatology · 2016 · 15 citations